Zeal Global cuts Evexia Lifecare stake by 3.1% in open-market exit
The foreign institutional investor sold 5.80 crore shares worth ₹9.5 crore in a week-long exit, slashing its holding to below 5%.
— 1 earlier story on Evexia Lifecare Ltd. →What's new
- Zeal Global sold 5.80 crore Evexia Lifecare shares from June 1-8, cutting its stake from 7.87% to 4.78%.
- The disposal was executed on the BSE at market prices and is now below the 5% disclosure threshold.
- The sale comes two days after prior coverage noted a new investor bought a 4.1% stake in the company.
Why this matters
A foreign institutional investor dumping 3.1% of a nano-cap in a single week is a material exit. For a company with a ₹295 crore market cap and a trailing P/E of 182.6, the loss of a significant non-promoter shareholder can unsettle a thinly traded stock. The sale's timing, just after another investor built a 4.1% position, creates competing narratives of inflow and outflow.
What we're watching
- Whether the new 4.1% investor is the counterparty to Zeal Global's sale.
- Trading volume and price action in Evexia shares following the disclosure.
- Any regulatory filings from Evexia explaining the stake change or its implications.
The full read
Zeal Global Opportunities Fund sold 5.80 crore Evexia Lifecare shares between June 1 and June 8, dropping its holding from 7.87% to 4.78%. At roughly ₹9.5 crore, the exit wipes out a 3.1% slice of a company with a ₹295 crore market cap. For a nano-cap lifecare firm trading at a trailing P/E of 182.6, the departure of a multi-percent foreign institutional holder is a weight on the register. The sale comes just two days after another investor disclosed a 4.1% stake, a ₹14.6 crore position. Whether those two moves are connected is unknown. What is clear: one large non-promoter holder has walked away. The timing, combined with Evexia's thin profits (net profit of ₹0 crore in the last quarter), makes this a liquidity event the stock may struggle to absorb.
Questions answered
- What was the size of Zeal Global's stake sale in Evexia Lifecare?
- Zeal Global sold 5.80 crore shares, reducing its holding from 7.87% to 4.78% of Evexia's equity. The transaction was worth approximately ₹9.5 crore, or about 3.1% of the company's ₹295 crore market cap.
- Why is this sale significant for a nano-cap company?
- Evexia has a market capitalization of just ₹295 crore and low liquidity. A 3.1% block by a foreign institutional investor over five trading days is a large portion of the company's free float to absorb, which can create downward price pressure.
- Is this sale related to the new 4.1% stake acquired on June 8?
- The filing provides no information on the buyer of the 4.1% stake. The timing is consecutive but whether the transactions are related (i.e., a private placement or off-market deal) is not disclosed.
- What is Evexia Lifecare's current financial health?
- In the latest reported quarter (December 2025), Evexia posted sales of ₹25 crore with net profit of ₹0 crore. The company trades at a trailing P/E of 182.6 and has a debt-to-equity ratio of 0.81.
Evexia Lifecare Ltd.
Latest quarter · Dec 2025
Strength & growth
Story so far
All notes on EVEXIA →- 11 Jun 2026 · 9:53 AM IST Zeal Global cuts Evexia Lifecare stake by 3.1% in open-market exit
- 3d ago A new investor just bought 4.1% of Evexia Lifecare